Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2025-12-29 @ 1:22 PM
Study NCT ID:
NCT07076095
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-21
First Post:
2025-07-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer
Sponsor:
SUNHO（China）BioPharmaceutical CO., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IBB0979-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |